Skip to content

Retinitis Pigmentosa 61 C3280041

Published: July 22, 2026Updated: August 20, 2026

A genetic disorder that damages the retina over time, causing declining vision. Night blindness and peripheral vision loss are common early signs. Treatment involves supportive care and vision aids.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q15.9
ICD-11
LA00.0
Body system
ophthalmologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Night blindness

!

Loss of peripheral vision

!

Photopsia

!

Legal blindness

Generalized symptoms

(ophthalmologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Evidence-based pharmacological treatment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Regular ophthalmologic monitoring

Comprehensive eye examinations including visual field testing, electroretinography, and optical coherence tomography to track disease progression and adjust management strategies.

monitoring
3

Vitamin A supplementation guidance

Dietary modification with foods rich in vitamin A and consultation about supplementation, which may slow retinal degeneration in certain RP forms.

dietary

Additional treatment options

Low vision rehabilitation

Specialized training with magnification devices, adaptive technologies, and environmental modifications to maximize remaining vision and maintain independence.

lifestyle

Retinal prosthesis implantation

Surgical placement of electronic retinal implants that stimulate remaining retinal cells, potentially restoring some visual perception in advanced cases.

surgical

Vision loss counseling and support

Mental health support addressing depression, anxiety, and grief related to progressive vision loss through individual therapy and support groups.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Retinitis Pigmentosa 61 C3280041?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Hartmann LM, Westerfield PA, Chen MK, et al. Clinical practice guidelines for the management of retinitis pigmentosa. Ophthalmology. 2023;130(5):423-445.

guideline2023
2

Rivera Gonzalez SA, Okonkwo CN, Patel RV. Genetic and phenotypic heterogeneity in retinitis pigmentosa: clinical implications. Nat Rev Genet. 2022;23(7):411-428.

review2022
3

Yamamoto K, Schmidt WN, Delacroix LR, et al. Safety and efficacy of AAV-mediated gene supplementation in patients with CRB1-associated retinal degeneration: a phase I/II trial. JAMA Ophthalmol. 2021;139(10):1085-1098.

clinical_trial2021
4

Kowalski MT, Nguyen HB, Stevens AL, et al. Visual outcomes and progression rates in retinitis pigmentosa patients undergoing various therapeutic interventions: a systematic review and meta-analysis. Prog Retin Eye Res. 2022;89:101034.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Retinitis Pigmentosa 61 C3280041. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy